The Extracellular Matrix Protein MAGP1 Supports Thermogenesis and Protects Against Obesity and Diabetes Through Regulation of TGF-β
暂无分享,去创建一个
S. Klein | R. Mecham | N. Abumrad | T. Coleman | T. Pietka | Timothy Schappe | C. Craft | Michelle D. Combs
[1] S. Klein,et al. Gastric bypass and banding equally improve insulin sensitivity and β cell function. , 2012, The Journal of clinical investigation.
[2] B. Spiegelman,et al. Beige Adipocytes Are a Distinct Type of Thermogenic Fat Cell in Mouse and Human , 2012, Cell.
[3] B. Spiegelman,et al. A Novel Therapeutic Approach to Treating Obesity through Modulation of TGFβ Signaling , 2012, Endocrinology.
[4] N. Tan,et al. Getting ‘Smad' about obesity and diabetes , 2012, Nutrition & Diabetes.
[5] B. Spiegelman,et al. FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis. , 2012, Genes & development.
[6] R. Mecham,et al. Oophorectomy‐induced bone loss is attenuated in MAGP1‐deficient mice , 2012, Journal of cellular biochemistry.
[7] P. Sun,et al. Protection from obesity and diabetes by blockade of TGF-β/Smad3 signaling. , 2011, Cell metabolism.
[8] Oliver T. Bruns,et al. Brown adipose tissue activity controls triglyceride clearance , 2011, Nature Medicine.
[9] Heinz Drexel,et al. Brown versus White Adipose Tissue: A Mini-Review , 2010, Gerontology.
[10] P. Robinson,et al. Marfan syndrome with neonatal progeroid syndrome‐like lipodystrophy associated with a novel frameshift mutation at the 3′ terminus of the FBN1‐gene , 2010, American journal of medical genetics. Part A.
[11] Justin S. Weinbaum,et al. Microfibril-associated Glycoprotein-1, an Extracellular Matrix Regulator of Bone Remodeling* , 2010, The Journal of Biological Chemistry.
[12] K. Kos,et al. SPARC: a key player in the pathologies associated with obesity and diabetes , 2010, Nature Reviews Endocrinology.
[13] X. Su,et al. ADP-ribosylation factor 6 modulates adrenergic stimulated lipolysis in adipocytes. , 2010, American journal of physiology. Cell physiology.
[14] C. Meisinger,et al. Transforming growth factor-beta1 and incident type 2 diabetes: results from the MONICA/KORA case-cohort study, 1984-2002. , 2009, Diabetes care.
[15] F. Segade. Functional evolution of the microfibril-associated glycoproteins. , 2009, Gene.
[16] Philipp E. Scherer,et al. Metabolic Dysregulation and Adipose Tissue Fibrosis: Role of Collagen VI , 2008, Molecular and Cellular Biology.
[17] Justin S. Weinbaum,et al. Deficiency in Microfibril-associated Glycoprotein-1 Leads to Complex Phenotypes in Multiple Organ Systems* , 2008, Journal of Biological Chemistry.
[18] R. Pierce,et al. Mice lacking the extracellular matrix protein MAGP1 display delayed thrombotic occlusion following vessel injury. , 2008, Blood.
[19] L. Carta,et al. Fibrillin-Rich Microfibrils—Structural and Instructive Determinants of Mammalian Development and Physiology , 2008, Connective tissue research.
[20] M. Lane,et al. Brain fatty acid synthase activates PPARα to maintain energy homeostasis , 2007 .
[21] Xianlin Han,et al. CD36 Is Important for Fatty Acid and Cholesterol Uptake by the Proximal but Not Distal Intestine* , 2007, Journal of Biological Chemistry.
[22] T. Wienker,et al. A German genome-wide linkage scan for type 2 diabetes supports the existence of a metabolic syndrome locus on chromosome 1p36.13 and a type 2 diabetes locus on chromosome 16p12.2 , 2007, Diabetologia.
[23] Stephen J. Weiss,et al. A Pericellular Collagenase Directs the 3-Dimensional Development of White Adipose Tissue , 2006, Cell.
[24] D. Keene,et al. Fibrillins 1 and 2 Perform Partially Overlapping Functions during Aortic Development* , 2006, Journal of Biological Chemistry.
[25] T. Hudson,et al. Genome-Wide Scan for Linkage to Obesity-Associated Hypertension in French Canadians , 2005, Hypertension.
[26] L. Adès,et al. Histopathology and fibrillin‐1 distribution in severe early onset Marfan syndrome , 2005, American journal of medical genetics. Part A.
[27] D. Keene,et al. Differential expression of fibrillin-3 adds to microfibril variety in human and avian, but not rodent, connective tissues. , 2004, Genomics.
[28] Hui Shen,et al. A follow-up linkage study for quantitative trait loci contributing to obesity-related phenotypes. , 2004, The Journal of clinical endocrinology and metabolism.
[29] E. Sage,et al. SPARC-null mice exhibit increased adiposity without significant differences in overall body weight , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[30] J. Ju,et al. Skeletal muscle respiratory uncoupling prevents diet-induced obesity and insulin resistance in mice , 2000, Nature Medicine.
[31] P. Morange,et al. Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity. , 2000, Diabetes.
[32] M. Mcdaniel,et al. Relative Hypoglycemia and Hyperinsulinemia in Mice with Heterozygous Lipoprotein Lipase (LPL) Deficiency , 1999, The Journal of Biological Chemistry.
[33] W. Hu,et al. Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils , 1995, The Journal of cell biology.
[34] R. Mecham,et al. Structure and expression of fibrillin-2, a novel microfibrillar component preferentially located in elastic matrices , 1994, The Journal of cell biology.
[35] E. Engvall,et al. Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils , 1986, The Journal of cell biology.
[36] R. Harris,et al. Metabolic response to a specific lipid-depleting factor in parabiotic rats. , 1986, The American journal of physiology.
[37] K. Nath,et al. Marfan's syndrome. , 1959, Journal of the Indian Medical Association.
[38] B. K. Sandwell. The French Canadians , 1947 .
[39] M. Lane,et al. Brain fatty acid synthase activates PPARalpha to maintain energy homeostasis. , 2007, The Journal of clinical investigation.
[40] M. Gibson,et al. Elastin-associated microfibrils and microfibrillar proteins. , 1983, International review of connective tissue research.